TY - JOUR
T1 - Surgical outcomes and quality of life assessment of esophagectomy for cancer with colon conduit via retrosternal route
AU - Long, Vo Duy
AU - Thong, Dang Quang
AU - Hai, Nguyen Viet
AU - Dat, Tran Quang
AU - Le Minh Quoc, Ho
AU - Nguyen, Doan Thuy
AU - Anh, Nguyen Vu Tuan
AU - Minh, Tran Anh
AU - Vuong, Nguyen Lam
AU - So, Jimmy Bok Yan
AU - Bac, Nguyen Hoang
AU - Uyama, Ichiro
N1 - Publisher Copyright:
© 2023, The Author(s) under exclusive licence to The Japan Esophageal Society.
PY - 2023/7
Y1 - 2023/7
N2 - Purpose: Colon conduit is an alternative to a gastric conduit for esophagectomy in patients that stomach is not available. Surgical technique is complex and has a high risk of morbidities and mortality. Outcomes of patients are still lacking in the literature, thus aims of this study are to evaluate the safety, feasibility and long-term functional outcomes of patients who underwent esophagectomy for cancer with colon conduit via retrosternal route. Methods: Twenty-six patients underwent operation between August 2016 and June 2021 for malignancies. Minimally invasive esophagectomy and laparotomy were performed in accordance with the 2017 Japan Esophageal Society’s guidelines. Colonic interposition was used for esophageal replacement. Outcomes were technical success, complications assessed using Clavien-Dindo classification, and patient’s quality of life (QOL) based on EORTC-QOL-OES18 questionnaire. Results: Mean age was 56.0 ± 9.9 years and 21 patients (80.8%) were men. Mean operating time was 432 ± 66 min. Technical success was 100%. The average number of resected lymph nodes was 26 ± 14. Twelve patients (46.2%) experienced postoperative complications: 7/12 were classified as grade I-II, 3/12 as grade III, 1/12 as grade IV, and 1/12 as grade V (death). Patient’s QOL improved during the follow-up period with median (25–75th percentiles) global EORTC-QOL-OES18 score was 29 (17–34); 13 (9–21), and 9 (6–16) at 3, 6, and 12 months, respectively. During the follow-up period, there were 4 late complications, 3 lymphatic recurrences, 5 distant metastases, and 6 deaths. Conclusions: Colon conduit via retrosternal route after esophagectomy is feasible, safe, and could provide acceptable long-term functional outcomes.
AB - Purpose: Colon conduit is an alternative to a gastric conduit for esophagectomy in patients that stomach is not available. Surgical technique is complex and has a high risk of morbidities and mortality. Outcomes of patients are still lacking in the literature, thus aims of this study are to evaluate the safety, feasibility and long-term functional outcomes of patients who underwent esophagectomy for cancer with colon conduit via retrosternal route. Methods: Twenty-six patients underwent operation between August 2016 and June 2021 for malignancies. Minimally invasive esophagectomy and laparotomy were performed in accordance with the 2017 Japan Esophageal Society’s guidelines. Colonic interposition was used for esophageal replacement. Outcomes were technical success, complications assessed using Clavien-Dindo classification, and patient’s quality of life (QOL) based on EORTC-QOL-OES18 questionnaire. Results: Mean age was 56.0 ± 9.9 years and 21 patients (80.8%) were men. Mean operating time was 432 ± 66 min. Technical success was 100%. The average number of resected lymph nodes was 26 ± 14. Twelve patients (46.2%) experienced postoperative complications: 7/12 were classified as grade I-II, 3/12 as grade III, 1/12 as grade IV, and 1/12 as grade V (death). Patient’s QOL improved during the follow-up period with median (25–75th percentiles) global EORTC-QOL-OES18 score was 29 (17–34); 13 (9–21), and 9 (6–16) at 3, 6, and 12 months, respectively. During the follow-up period, there were 4 late complications, 3 lymphatic recurrences, 5 distant metastases, and 6 deaths. Conclusions: Colon conduit via retrosternal route after esophagectomy is feasible, safe, and could provide acceptable long-term functional outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85145675504&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85145675504&partnerID=8YFLogxK
U2 - 10.1007/s10388-023-00984-3
DO - 10.1007/s10388-023-00984-3
M3 - Article
C2 - 36609618
AN - SCOPUS:85145675504
SN - 1612-9059
VL - 20
SP - 435
EP - 444
JO - Esophagus
JF - Esophagus
IS - 3
ER -